Research & Development
14 October 2026 - Biopharmaceutical company Legacy Healthcare announced on Tuesday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to CINAINU (LH-8), its in...
14 October 2026 - Medical technology company Vantis Vascular announced on Tuesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for a new 6 French (6F) model of ...
13 October 2026 - Blue Lake Biotechnology Inc, a clinical-stage intranasal vaccine company, on Monday reported the presentation of interim data from the company's Phase 1/2a paediatric clinical t...
13 October 2026 - Commercial-stage biopharmaceutical company Shanghai Ark Biopharmaceutical Co Ltd ('ArkBio') announced on Monday that the US Food and Drug Administration (FDA) has granted i...
13 October 2026 - Agilent Technologies Inc (NYSE:A), a provider of analytical and clinical laboratory technologies, announced on Tuesday that it has signed a definitive agreement to acquire Proscia, a...
12 October 2026 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Monday announced positive topline results from the planned interim analysis of the Phase 3 ACTION-1 trial evaluating RYZ1...